Skip to main content
. 2022 Aug 23;328(8):719–727. doi: 10.1001/jama.2022.13416

Figure 3. Kaplan-Meier Analysis of Time to Venous Thromboembolism (Deep Venous Thrombosis or Pulmonary Embolism) Occurrence by Randomized Group.

Figure 3.

Shaded areas indicate 95% confidence intervals. Median time to venous thromboembolism in the aspirin group was 7.5 days (IQR, 5-9 days); median time to venous thromboembolism in the enoxaparin group was 12 days (IQR, 7-25 days).

aThree patients in the aspirin group who experienced a venous thromboembolism did not have a date of event recorded and are excluded from this analysis.